Abstract
Overactive urinary (OAB) syndrome affects millions of individuals worldwide. The personal, financial and economic cost of OAB is enormous. Therefore, novel treatments are required. Theis Editorial focus highlights the recent study by Hristov and co-workers on the role of TRPM4 in human urinary bladder function.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
